cabecera

Scientific Program

  • Auditorio 2 (Ground Floor)
    08:45-09:00 OPENING AND WELCOME OF PGDIS 2017.
    Anver Kuliev (USA) and Carlos Simon (Spain)
     09:00-09:30 PLENARY LECTURE
    Genetic contribution to human disease, the impact of personalized medicine.
    Angel Carracedo (Spain)

     09:30-10:30 SESSION 1: UNDERSTANDING THE GENETIC RISK OF THE COUPLE
    Chairmen: Anver Kuliev (USA) and Carlos Simón (Spain)

    09:30-10:00 Personalized vs. Extended panels
    Santiago Munné (USA)
    10:00-10:30 Should we be testing all sperm/egg donors
    Julio Martin (Spain)
    10:30-11:00 COFFEE BREAK 
    11:00-13:00 SESSION 2: INTRINSIC FACTORS CONTRIBUTING TO EMBRYO ANEUPLOIDY
    Chairmen: Tony Gordon (UK) and Mireia Sandalinas (Spain)

    11:00-11:30 Common variants associated with mitotic-origin of aneuploidy in human embryos
    Rajiv Mc Coy (USA)
    11:30-12:00 Relationships between cancer and aneuploid
    Melvin DePamphilis (USA)
    12:00-12:30 Implications of MTHFR gene polymorphisms in embryo viability and aneuploidy
    Dagan Wells (UK)
    12:30-13:00 Embryo aneuploidy induced by the sperm
    Moncef Benkhalifa (France)
    13:00-14:00 LUNCH BREAK - Exhibition Area
    FREE POSTER SESSION -
    Multiusos 1 room (1st Floor)
    14:00-15:30 SESSION 3: FREE COMMUNICATIONS (RELATED TO CARRIER SCREENING AND PGD)
    Chairman: Filipa Carvalho (Portugal) and Xavi Vendrell (Spain)

    14:00-14:15 OC-01.
    THERAPEUTIC SUCCESS OF HSCT BY PREIMPLANTATION HAPLOTYPING, FOLLOW-UP OF 520 CYCLES.
    Cetinkaya, Murat
    14:15-14:30 OC-02.
    COMBINED PGS AND PGD FOR THALASSEMIA.
    Brockman, Matthew
    14:30-14:45 OC-03.
    HAPLOTYPING AND COPY-NUMBER PROFILING OF SINGLE CELLS BY MASSIVE PARALLEL SEQUENCING.
    Masset, Heleen
    14:45-15:00 OC-04.
    FROM PRENATAL DIAGNOSIS OF FETAL ABNORMALITY TO PREIMPLANTATION GENETIC DIAGNOSIS FOR SKELETAL DYSPLASIA USING NEXT-GENERATION SEQUENCING TECHNOLOGIES.
    Penacho, Vanessa
    15:00-15:15 OC-05.
    SEGMENTAL ANEUPLOIDIES IN PGD CYCLES FOR SINGLE GENE CONDITIONS BY KARYOMAPPING.
    Vesela, Katerina
    15:15-15:30 OC-06.
    PREDICTION OF MENDELIAN DISORDERS RISK IN ASSISTED REPRODUCTIVE TECHNOLOGY PATIENTS OF MIDDLE EASTERN ETHNICITY BASED ON DETECTION OF GERMLINE VARIANTS USING AN EXPANDED PRECONCEPTION CARRIER GENETIC SCREENING TEST.
    Martin, Julio
    15:30-16:00 COFFEE BREAK 
    16:00-17-30 SESSION 4: EXTRINSIC FACTORS CONTRIBUTING TO EMBRYO ANEUPLOIDY
    Chairmen: Darren Griffin (UK) and Amparo Mercader (Spain)

    16:00-16:30 Controlled Ovarian Stimulation
    Jason Franasiak, (USA)
    16:30-17:00 Embryo culture conditions and more
    María José de los Santos Molina (Spain)
    17:00-17:30 Impact of Lifestyle & Environment on Embryo aneuploidy
    Ursula Eichenlaub-Ritter (Germany)
  • Auditorio 2 (Ground Floor)
    08:00-08:15 SUMMARY OF HIGHLIGHTS PREVIOUS DAY AND INTRODUCTION TO SECOND DAY
    Svetlana Rechistky (USA)
    08:15-08:45 PLENARY LECTURE
    Mouse model of chromosome mosaicism reveals  lineage-specific depletion of aneuploid cells and normal developmental potential.
    Magdalena Zernicka-Goetz (UK)
    08:45-10:30 SESSION 5: CHALLENGING PGD-A DIAGNOSIS. MOSAICISM
    Chairmen: David Cram (China) and Gary Harton (USA)

    08:45-09:00 How to report and counsel mosaicism and segmentals in PGD-A
    Don Leigh (Australia)
    09:00-09:15 Mosaicism and segmentals in POCs and prenatal diagnosis
    David Cram (China)
    09:15-10:15 Specific Views (from submitted abstracts)
    Chairmen: Gary Harton (USA), David Cram (China)

    09:15-09:30
    OC-07. CHALLENGES IN INTERPRETING THE RELEVANCE OF SEGMENTAL MOSAICISM DETECTED BY NGS.
    Grkovic, Steve

    09:30-09:45
    OC-08. THE EXTENT OF CHROMOSOMAL MOSAICISM INFLUENCES THE CLINICAL OUTCOME OF IN VITRO FERTILIZATION TREATMENTS.
    Spinella, Francesca

    09:45-10:00
    OC-09. EMBRYO AND PATERNAL FACTORS ASSOCIATED WITH BLASTOCYST CHROMOSOMAL MOSAICISM.
    Lledo Bosch, Belén

    10:00-10:15
    OC-10. CUSTOM NGS ALGORITHM FOR CONSISTENT AND ACCURATE DIAGNOSIS OF MOSAICISM IN TROPHECTODERM BIOPSIES.
    Vera-Rodriguez, Maria
    10:15-10:30 Conclusion
    Joe Leigh Simpson (USA)
    10:30-11:00 COFFEE BREAK
     11:00-13:00 SESSION 6: HOW TO IMPROVE CLINICAL OUTCOME IN PGD-A
    Chairmen: Katerina Vesela (Czech Republic) and Mónica Parriego (Spain)

    11:00-11:30 Laboratory conditions/biopsy strategies
    Laura Rienzi (Italy)
    11:30-12:00 When to transfer? Fresh vs. deferred transfer
    Semra Kahraman (Turkey)
    12:00-12:30 Review of the clinical evidence of MtDNA for embryo viability:
    Luca Gianaroli (Italy)
    12:30-13:00 What about the maternal endometrium. The search for the personalized WOI and Microbiota:
    Carlos Simón (Spain)
    13:00-14:00 LUNCH BREAK - Exhibition Area
    FREE POSTER SESSION - Multiusos 1 room (1st Floor)
    14:00-15:30 SESSION 7: FREE COMMUNICATIONS (RELATED TO PGD-A, MOSAICISM, BIOPSY)
    Chairmen: Edith Coonen (Netherlands) and Carles Giménez (Spain)

    14:00-14:15 OC-11.
    ANEUPLOIDY RATES ARE ASSOCIATED WITH THE BLASOTCYST BIOPSY TECHNIQUE.
    Whitney, John B
    14:15-14:30 OC-12.
    MITOCHONDRIAL DNA COPY NUMBER MEASURED BY MITOSCORE IS ASSOCIATED TO TROPHECTODERM QUALITY.
    De Los Santos, Maria José
    14:30-14:45 OC-13.
    THE INCIDENCE AND ORIGIN OF SEGMENTAL CHROMOSOME ABNORMALITIES IN HUMAN IVF EMBRYOS DETECTED DURING PGD AND PGS.
    Hornak, Miroslav
    14:45-15:00 OC-14.
    CLINICAL SIGNIFICANCE OF UNDIAGNOSED MOSAICISM IN IVF EMBRYOS.
    Perry, Emma
    15:00-15:15 OC-15.
    MITOSCORE VALUES ARE NOT AFFECTED BY ATMOSPHERIC OXYGEN CONCENTRATION DURING EMBRYO CULTURE.
    Mifsud, Amparo
    15:15-15:30 OC-16.
    HOW TO CHOOSE PRENATAL TESTING OPTIONS FOR PREGNANT WOMEN AFTER PREIMPLANTATION GENETIC SCREENING: GENETIC COUNSELING CHALLENGES.
    Tamura, Chieko
    15:30-16:00 COFFEE BREAK
    16:00-17:30 SESSION 8: BORDER-LINE INDICATIONS FOR PGD
    Chairmen: Martine De Rycke (Belgium) and Alan Handyside (UK)

    16:00-16:30 PGD for HLA (ESHRE data collection)
    Georgia Kakourou (Greece)
    16:30-17:00 Experience in PGD for Cancer
    Svetlana Rechistky (USA)
    17.00-17:30 Current limitations of Karyomapping
    Alan Handyside (UK)
  • Auditorio 2 (Ground Floor)
    08:00-08:15 SUMMARY OF HIGHLIGHTS PREVIOUS DAY AND INTRODUCTION TO THIRD DAY
    Alan Handyside (UK)
    08:15-09.00 PLENARY SESSION
    Gene editing for nuclear and mithocondrial DNA mutations
    Juan Carlos Izpizua (USA)
    09:00-10:30

    SESSION 9: FREE COMMUNICATIONS (RELATED TO NEW TECHNOLOGIES, NON INVASIVE, ETC)
    Chairmen:  Joe Leigh Simpson (USA) and David Blesa (Spain)

    09:00-09:15 OC-17.
    DETECTION OF SEGMENTAL ANEUPLOIDY AND MOSAICISM IN PREIMPLANTATION EMBRYO MODEL BY NEXT GENERATION SEQUENCING METHODOLOGIES.
    Biricik, Anil
    09:15-09:30 OC-18.
    EVIDENCE TO SUGGEST A UNIQUE 3D ORGANIZATION OF CHROMOSOMES WITHIN THE SPERM NUCLEUS: IMPLICATIONS FOR FERTILIZATION AND EARLY
    EMBRYONIC DEVELOPMENT.
    Tempest, Helen
    09:30-09:45 OC-19.
    A NOVEL ALGORITHM FOR DETERMINING THE LEVEL OF MOSAICISM IN PREIMPLANTATION GENETIC SCREENING (PGS) WITH NEXT-GENERATION SEQUENCING (NGS).
    Castejon Fernandez, Natalia
    09:45-10:00 OC-20.
    COMBINED PGD AND PGS BY NGS ON THE SAME BIOPSY USING A SINGLE INDEX.
    Jasper, Melinda
    10:00-10:15 OC-21.
    MATERNAL AGE HAS NO INFLUENCE ON MITOCHONDRIAL DNA (MTDNA) CONTENT IN CHROMOSOMALLY NORMAL EMBRYOS.
    Ogur, Cagri
    10:15-10:30 OC-22.
    DETECTION LIMIT OF PARTIAL INSERTIONS AND DELETIONS FOR PGS IN TERMS OF NGS BY ANALYZING 242 EMBRYOS OF COUPLES WITH BALANCED TRANSLOCATIONS.
    Blanca, Helena
    10:30-11:00 COFFEE BREAK
    11:00-13:00 SESSION 10: THE NEAR FUTURE
    Chairmen: Samir Hammamah (France) and Antonio Díez-Juan (Spain)

    11:00-11:30 Cumulus analysis to predict pregnancy potential
    Johan Smitz (Belgium)
    11:30-12:00 Ovarian rejuvenation. Is that for real?
    Antonio Pellicer (Italy) and Sonia Herráiz (Spain)
    12:00-12:30 Epigenetics in the male factor
    Michael Skinner (USA)
    12:30-13:00 Concurrent preimplantation genetic diagnosis for single gene disorders and comprehensive chromosomal aneuploidy testing without whole genome amplification
    Rebekah Zimmerman (USA)
    13:00-14:00 LUNCH BREAK - Exhibition Area
    FREE POSTER SESSION
    - Multiusos 1 room (1st Floor)
    14:00-15:30 SESSION 11: REMOVING BARRIERS TO ADOPT GENETIC TEST IN REPRODUCTIVE MEDICINE
    Chairmen: Joe Leigh Simpson (USA) Alan Thornhill ( UK)

    14:00-14:30 Carrier Screening. Disease prevention vs cost effectiveness
    Jason Franasiak (USA)
    14:30-15:00 Obstacles to implement PGD-A in ART
    David Jiménez (Spain)
    15:00-15:30 How are we perceived by our clinical fellows? Critical review of SART and ESHRE data
    Kangpu Xu (USA)
    15:30-16:30 SESSION 12: LATE-BREAKING SESSION. RCTS/ NON- INVASIVE PGD
    Chairman: Carmen Rubio (Spain) and Antonio Capalbo (Italy)

    Non invasive analysis of the embryonic genome: a critical review of non invasive approaches for PGD and PGS
    Antonio Capalbo (Italy)
    PGD-A in advanced maternal age: final results of a day-3 biopsy RCT
    Carmen Rubio (Spain)
    16:30-17:00 CLOSING REMARKS AND PRESENTATION OF NEXT MEETING  
GRUPO PACIFICO
TECHNICAL SECRETARIAT
Pº Gral Mtnez Campos 9-2º
28010 Madrid (SPAIN)
Tel. +34 913 836 000 | Fax. +34 913 023 926
This email address is being protected from spambots. You need JavaScript enabled to view it.
Website created by:
Grupo Pacífico